Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
- Analysis Technique
- Analyzed With
- Chemical Group
- Compounds
- Detection Technique
- Injection Technique
- Instrument
- Analysis Platform
- Language
- Publication Date
21 - 40 of 82 results
Applied Filters
必威体育登录手机A demonstration of how the Agilent xCELLigence RTCA eSight real-time imaging platform can be used to monitor induction of the unfolded protein response using a genetically encoded fluorescent sensor.
必威体育登录手机A demonstration of how the Agilent xCELLigence RTCA eSight real-time imaging platform can be used to monitor phagocytosis, using a model system comprising macrophages and E.coli cells conjugated to a pH-sensitive fluorescent dye.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
A demonstration of how the eSight combines the strengths of real-time impedance monitoring with those of live cell imaging, to increase the information richness of your proliferation assays while simultaneously reducing the workload.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
To determine if the stimulation of endogenously expressed GPCRs can be monitored by the xCELLigence system, cells were stimulated with various receptor agonists, triggering either Gs-, Gi-, or Gq-mediated downstream signals.
A demonstration of combining microelectrode-based iPS cardiomyocyte contractility measurements with microplate-based bioenergetics assessment to characterize cellular responses to drug treatment.
必威体育登录手机Using the Agilent xCELLigence RTCA eSight to continuously monitor CAR T cell-mediatedkilling of cancer cells over the course of multiplae days.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
必威体育登录手机A 16-color T cell immunophenotyping panel was developed for the Agilent NovoCyte Advanteon to simultaneously analyze T cell differentiation, activation, exhaustion, and functional output through degranulation and cytokine expression
| Chinese (Simplified) (China) | Complete (PDF) |
|---|---|
| Russian (Russia) | Complete (PDF) |
| German (Germany) | Complete (PDF) |
| Korean (Korea) | Complete (PDF) |
| French (France) | Complete (PDF) |
| Italian (Italy) | Complete (PDF) |
Two workflows using MitoXpress Xtra and pH-Xtra probes to investigate cell metabolism in intact RAFT 3D collagen structures on fluorescent plate readers.
Respiratory Syncytial Virus Infection application brief outlining Seahorse XF applications in infectious diseases
In this application note, we used the xCELLigence RTCA CardioECR system (CardioECR system) in conjunction with hiPS-CMs for the assessment of preclinical cardiac risks.
必威体育登录手机This application note presents a method for improving human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) maturation using the Agilent xCELLigence RTCA ePacer system.
Influenza application brief outlining Seahorse XF applications in infectious diseases
Combining real-time extracellular flux information with 13C stable‑isotope‑tracing allows greater insight into the mechanism of macrophage activation.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
Norovirus application brief outlining Seahorse XF applications in infectious diseases
必威体育登录手机Using the Agilent xCELLigence RTCA system to assess both the selectivity and potency of the TCR-engineered TILs toward HLA restricted cells.
Examines the phosphorylation of signal transducer and activator of transcription (STAT) proteins in response to cytokine stimulation using a phosphoflow technique.
必威体育登录手机Describes the ability of the Agilent NovoCyte Quanteon flow cytometer to resolve small particles, including cell-derived extracellular vesicles (EV) and beads.
必威体育登录手机A demonstration of the performance of the Agilent MitoXpress Xtra oxygen consumption assay for identifying drug induced mitocondrial toxicity.
This application note highlights the affect that carbon source modification has on deriving neural cell lineages from stem cells.
必威体育登录手机Measuring bioenergetic phenotype, cellular ATP production rates, and mitochondrial and glycolytic function with Agilent Seahorse XF technology can reveal metabolic vulnerabilities in cancer cells to advance cancer therapeutics.